Similarly, a French study also confirmed this conclusion; the researchers found that the expression of PD-L1 was decreased, and the density of CD8+T lymphocytes was lower in patients with EGFR mutations in lung cancer through IHC. The gene discussed is EGFR; the disease is lung carcinoma.